Literature DB >> 18093122

Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis.

Yasuni Nakanuma1, Motoko Sasaki, Hiroko Ikeda, Yasunori Sato, Yoh Zen, Kazuto Kosaka, Kenichi Harada.   

Abstract

Cholangiocarcinomas (CCs) are neoplasms with cholangiocyte differentiation, and may arise from cholangiocytes of the biliary tree and possibly cholangiocyte progenitor cells. Intrahepatic CCs can be divided into the perihilar and peripheral types. Peripheral CCs present grossly as a mass forming tumor, and histologically as an adenocarcinoma of varying shapes and phenotypes. Some peripheral CCs (ductular type) are characterized by: (i) a histological resemblance to reactive bile ductules; (ii) the expression of neural cell adhesion molecule (NCAM) and vimentin. This type shows: (i) grossly, a blurred border; and (ii) histologically, carcinoma cells replacing the adjoining hepatocytes at the border of the tumor. It is frequently associated with neutrophilic infiltration and also with granulocyte and granulocyte macrophage colony-stimulating factors. We propose to call this type "ductular CC." The other peripheral CC (duct type) includes ordinary adenocarcinoma with well to moderately differentiated tubular and micropapillary patterns and is negative for NCAM but positive for mucin. This type can be called "duct CC," and shows a rather compressive growth. Interestingly, CC components of combined hepatocellular CC share the features of ductular CC, suggesting that hepatic progenitor cells may be involved in the tumorigenesis of ductular CC. The biological behavior of ductular CC and duct CC remains obscure, and follow-up and molecular studies on these tumors are required in order for these two CCs to be recognized as disease entities, and so as to evaluate their carcinogenesis.

Entities:  

Year:  2007        PMID: 18093122     DOI: 10.1111/j.1872-034X.2007.00312.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  A case of intrahepatic clear cell cholangiocarcinoma.

Authors:  Eo Toriyama; Atsushi Nanashima; Hideyuki Hayashi; Kuniko Abe; Naoe Kinoshita; Shunsuke Yuge; Takeshi Nagayasu; Masataka Uetani; Tomayoshi Hayashi
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients.

Authors:  Wei Shi; Gulimire Hasimu; Yan Wang; Ning Li; Mingquan Chen; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

3.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

4.  Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.

Authors:  Yasuni Nakanuma; Motoko Sasaki; Yasunori Sato; Xiangshan Ren; Hiroko Ikeda; Kenichi Harada
Journal:  World J Hepatol       Date:  2009-10-31

5.  Comparison of clinicopathological characteristics between cirrhotic and non-cirrhotic patients with intrahepatic cholangiocarcinoma: A large-scale retrospective study.

Authors:  Lei Yuan; Xianwu Luo; Xinyuan Lu; Bin Yi; Kaijian Chu; Quanyu Cai; Xiaoqing Jiang
Journal:  Mol Clin Oncol       Date:  2017-08-22

6.  Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma.

Authors:  Elena Panettieri; Harufumi Maki; Bradford J Kim; HyunSeon Christine Kang; Veronica Cox; Eduardo A Vega; Takashi Mizuno; Shubham Pant; Milind Javle; Jean-Nicolas Vauthey; Yoshikuni Kawaguchi
Journal:  Surg Oncol       Date:  2021-12-31       Impact factor: 3.279

7.  Expression of hepatocyte markers in mass-forming peripheral and periductal-infiltrating hilar intrahepatic cholangiocarcinomas.

Authors:  Hiroya Iida; Masaki Hata; Ayako Kakuno; Hiroshi Hirano; Koji Yamanegi; Naoko Yamada; Hideki Ohyama; Nobuyuki Terada; Chiaki Yasui; Naoki Yamanaka; Keiji Nakasho
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

8.  Neural cell adhesion molecule and polysialic acid in ductular reaction: the puzzle is far from completed, but the picture is becoming more clear.

Authors:  Mario Strazzabosco; Luca Fabris
Journal:  Hepatology       Date:  2014-10-01       Impact factor: 17.425

Review 9.  Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.

Authors:  Kelly J Lafaro; David Cosgrove; Jean-Francois H Geschwind; Ihab Kamel; Joseph M Herman; Timothy M Pawlik
Journal:  Gastroenterol Res Pract       Date:  2015-05-19       Impact factor: 2.260

Review 10.  Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review.

Authors:  Mukul Vij; Yogesh Puri; Ashwin Rammohan; Gowripriya G; Rajesh Rajalingam; Ilankumaran Kaliamoorthy; Mohamed Rela
Journal:  World J Gastrointest Oncol       Date:  2022-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.